Class Notes

Class Notes | Obituaries

Submit a Class Note or Obituary »

Showing class notes submitted in the last year by graduates in 1978

1978

'78
Ryan, Kathy

 Accounting Today, a national magazine for public accounting professionals, has recently named Kathy Ryan '78 to its 2014 Managing Partner Elite list for her innovation in staffing, technology, and strategy. Ryan co-founded RoseRyan, a Silicon Valley-based accounting and finance consulting firm, in 1993. She serves as the firm’s CEO and CFO. In 2012, the San Jose/Silicon Valley Business Journal named Ryan one of the most influential women in Silicon Valley that year for her success in effecting change in her industry and her community.

submitted Oct. 30, 2014 10:08A
UGRD Arts & Sciences '78
Maher, Patrick

Patrick J. Maher ’78 has been elected as Section Representative to the Board of Directors of the State Bar of Texas. Mr. Maher previously served as the Chair of the State Bar’s Council of Section Chairs for the last two years, and Chair of the State Bar’s Labor and Employment Law Section in 2010. He is Board Certified in Labor and Employment Law and a Fellow of the College of Labor and Employment Law.

submitted Apr. 1, 2014 11:39A
'78
Lovejoy, Steven

Steven Lovejoy 78 has retired after 24 years as a chemist at Lockheed Martin Space Systems and is now living with his husband Thane Kreiner, executive director of SCU's Center for Science, Technology and Society, in Sebastopol, Calif.

submitted Jan. 5, 2014 8:13A
'78
Hubbard, John
John Hubbard '78 has been appointed CEO of BioClinica, a leading provider of specialty outsourced clinical trial services. He is also a member of the company's board of directors. A seasoned pharmaceutical executive, Dr. Hubbard, 58, will join the company from Pfizer Inc., where he has served as senior vice president and worldwide head of development operations. During his 30-year career, Dr. Hubbard has spearheaded pharmaceutical research and development initiatives for some of the industry's premier organizations.  At Pfizer, he was responsible for more than 450 Phase 1-4 clinical projects per year.  He also served on the taskforce that redesigned Pfizer's research and development organization.
 
Prior to Pfizer, Dr. Hubbard was group president of ICON plc's clinical research services business, the company's largest business division. During his tenure, ICON was named one of the country's fastest growing companies by FORTUNE.  Dr. Hubbard also has held management positions at PAREXEL International Corporation, Revlon Health Care Group and Hoechst Marion Roussel Pharmaceuticals (now owned by Sanofi).
 
 
Dr. Hubbard is a member of the Society of Clinical Pharmacology and Therapeutics, Drug Information Association and has served on its Special Interest Advisory Committee on Project Management.  He is a board certified diplomat in applied pharmacology and was elected as a fellow of the American College of Clinical Pharmacology (ACCP).  Dr. Hubbard has authored and co-authored articles and chapters on biopsychology, cardiovascular, clinical pharmacology and global drug development.  He received his bachelor's degree in biopsychology from the University of Santa Clara and a doctorate from the University of Tennessee.  Dr. Hubbard was a National Institute of Health postdoctoral fellow in cardiovascular and clinical pharmacology at the University of Texas Health Sciences Center.

 

submitted Nov. 21, 2014 6:21P
'78
Hartnett, Jim

Jim Hartnett J.D. '78 is the current vice chair of the California High Speed Rail Authority Board. He maintains his active litigation and dispute resolution practice as a partner at Hartnett, Smith and Paetkau in vibrant downtown Redwood City. He's a former mayor of Redwood City.

submitted May. 4, 2014 1:06P

Search all notes/obituaries: